FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

APOLLOHOSP Share Price Discussion

Apollo Hospitals Enterprise Ltd.
NSE: APOLLOHOSP | BSE: 508869 | ISIN: INE437A01024 | Sector: Pharmaceuticals and health care

APOLLOHOSP Rating

5/5 (6 Ratings)
APOLLOHOSP Share Price *
1,195 +106.15 (9.75%)
* (quote may be delayed)
Find answers to all your questions on live APOLLOHOSP message board: Is APOLLOHOSP buy or sell? Should I buy APOLLOHOSP shares? Why are APOLLOHOSP shares falling? Should I invest in APOLLOHOSP stock?

You can also check APOLLOHOSP share price target recommended by brokerages.

APOLLOHOSP Discussion Forum


*Futures & Options educational trades for the week 7.3.20 to 10.4.20*
(My trade rules apply).
*Only for those with risk appetite*
#stockmarket
Apollohosp* cmp 1188.40 buy upto 1140.00 stop 1117.00 target 1295.00+
1
reply
Reply
@newsbot • Reputation: 2,602
Lucky 7: HDFC Securities picks fundamentally strong stocks for your portfolio
In the interim we may see values dip sharply again and again based on over discounting of fundamental deterioration or technical reasons like large selling by FPIs due to risk aversion
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,602
Experts name 10 safe bets as valuations seem attractive amid market turmoil
Vineeta Sharma of Narnolia Financial Advisors said the sharp fall in valuation was an opportunity for prudent long term equity investors.
Moneycontrol
Like
reply
Reply
@albert • Reputation: 3
APOLLOHOSP APR20 1100 PE

Type
Buy
Instrument
APOLLOHOSP APR20 1100 PE
Entry Price
₹74
Price@Trade
₹74.35
Target Price
₹200
Stop Price
₹50
Valid Till
Apr 3, 2020 3:20 AM  Apr 29, 2020 3:20 AM
Margin
₹37,000 approx for 500 Qty
Status
Active
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Apr 3 4:06 AM

Update
Trade Entered
Entry Price
₹74
Albert Wesker @albert
Apr 3 4:23 AM

Update
Time Extended
Price @ Update
₹64.95
Original Time
Apr 3, 2020 3:20 AM
New Time
Apr 29, 2020 3:20 AM
@newsbot • Reputation: 2,602
Coronavirus pandemic: This is how India is trying to overcome ventilator shortage
Experts say, if COVID-19 cases surge in days ahead, we may struggle as nearly 3 percent of COVID-19 patients would require ventilators.
Moneycontrol
Like
reply
Reply
@marketbull • Reputation: -32,320
APOLLOHOSP APR20 FUT

Type
Buy
Instrument
APOLLOHOSP APR20 FUT
Entry Price
₹1,100.6
Price@Trade
₹1,100.6
Target Price
₹1,200
Stop Price
₹1,050
Valid Till
Mar 31, 2020 3:20 AM
Margin
₹199,441.21 approx for 500 Qty
Status
Exited
Exit Price
₹1,123.9
Net P&L
5.84% Profit
Like
reply
Reply (1)
Latest replies
BULL KING @marketbull
Mar 31 5:21 AM

Update
Exited
Exit Price
₹1,123.9
Net P&L
5.84% Profit
@marketbull • Reputation: -32,320
APOLLOHOSP APR20 FUT

Type
Buy
Instrument
APOLLOHOSP APR20 FUT
Entry Price
₹1,118.2
Price@Trade
₹1,118.2
Target Price
₹1,200
Stop Price
₹1,080
Valid Till
Mar 31, 2020 3:20 AM
Margin
₹200,063.37 approx for 500 Qty
Status
Stoploss Hit
Exit Price
₹1,080
Net P&L
-9.55% Loss
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Mar 31 3:38 AM

Update
Stoploss Hit
Exit Price
₹1,080
@newsbot • Reputation: 2,602
Covid-19: Apollo teams up with OYO, Lemon Tree, Ginger Hotels to create 5,000 isolation rooms
Joining hands with partners including HUL, SBI and OYO, Apollo Hospitals plans to scale this capacity to up to 5,000 rooms where patients can stay in isolation.
Moneycontrol
Like
reply
Reply

Sell
Apollo hospital
CMP-1095
TGT-1080_1070_1050
Sl-1115
April fut
Like
reply
Reply
@tsr • Reputation: -10,930
APOLLOHOSP APR20 FUT

Type
Buy
Instrument
APOLLOHOSP APR20 FUT
Entry Price
₹1,143
Price@Trade
₹1,143.75
Target Price
₹1,168
Stop Price
₹1,120
Valid Till
Mar 30, 2020 3:20 AM
Margin
₹210,661.56 approx for 500 Qty
Status
Stoploss Hit
Exit Price
₹1,120
Net P&L
-5.46% Loss
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Mar 30 4:18 AM

Update
Trade Entered
Entry Price
₹1,143
TrackerBot @trackerbot
Mar 30 5:57 AM

Update
Stoploss Hit
Exit Price
₹1,120
@newsbot • Reputation: 2,602
COVID-19 impact | Private hospitals hit hard, steep drop in OPD footfalls
Even India's largest healthcare chains like Apollo Hospitals has warned about the "total crash of the system" if government doesn't step in .
Moneycontrol
Like
reply
Reply
@mohan-B1lZEEB1E • Reputation: -45,188
APOLLOHOSP APR20 1300 CE

Type
Buy
Instrument
APOLLOHOSP APR20 1300 CE
Entry Price
₹60
Price@Trade
₹60
Target Price
₹120
Stop Price
₹0
Valid Till
Apr 30, 2020 3:20 AM
Margin
₹30,000 approx for 500 Qty
Status
Active
Like
reply
Reply
@newsbot • Reputation: 2,602
'Fall in valuation, opportunity for investment but be selective'
Early indication suggests 4-6 weeks of near-complete washout of corporate earnings. Household and business stress implies a very difficult situation even for Indian financials.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,602
Lockdown, social distancing, visa cancellations to hit hospital earnings
As the situation remains uncertain, the sector is likely to remain under pressure over short to medium term, says Edelweiss.
Moneycontrol
Like
reply
Reply
APOLLOHOSP MAR20 FUT

Type
Buy
Instrument
APOLLOHOSP MAR20 FUT
Entry Price
₹1,134.75
Price@Trade
₹1,134.75
Target Price
₹1,234
Stop Price
₹1,100
Valid Till
Mar 25, 2020 3:20 AM
Margin
₹555,464.11 approx for 500 Qty
Status
Validity Over
Exit Price
₹1,168.25
Net P&L
3.02% Profit
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Mar 25 8:50 AM

Update
Validity Over
Exit Price
₹1,168.25
Net P&L
3.02% Profit
@RUDRA007 • Reputation: 2,798
RUDRA ANSH OF SHIV in APOLLOHOSP
APOLLO HOSPITAL CMP 1130 BUY AT CMP ADD MORE AR...

APOLLOW HOSPITAL CMP 1220 ,, KEEP BOOKING OR TRAILING AS PER COMFORT
Like
reply
Reply
@RUDRA007 • Reputation: 2,798

APOLLO HOSPITAL CMP 1130
BUY AT CMP
ADD MORE AROUND 1100
STOPLOSS OF 1088
TARGETS OF 1200-1250-1300-1350
#ApolloHospital
Like
reply
Reply
@newsbot • Reputation: 2,602
Kotak upgrades 14 stocks to buy in March after the virus-led correction
Given the sharp fall in stock prices across sectors, most experts advised accumulating quality and fundamentally strong scrips with a long term perspective.
Moneycontrol
Like
reply
Reply
@qasim-rk-hj9cZI • Reputation: -5,556
APOLLOHOSP MAR20 FUT

Type
Sell
Instrument
APOLLOHOSP MAR20 FUT
Entry Price
₹1,295
Price@Trade
₹1,294
Target Price
₹1,250
Stop Price
₹1,325
Valid Till
Mar 26, 2020 3:20 AM
Margin
₹179,403.2 approx for 500 Qty
Status
Stoploss Hit
Exit Price
₹1,325
Net P&L
-8.36% Loss
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Mar 20 7:51 AM

Update
Trade Entered
Entry Price
₹1,295
TrackerBot @trackerbot
Mar 20 8:34 AM

Update
Stoploss Hit
Exit Price
₹1,325
@qasim-rk-hj9cZI • Reputation: -5,556
APOLLOHOSP MAR20 FUT

Type
Buy
Instrument
APOLLOHOSP MAR20 FUT
Entry Price
₹1,275
Price@Trade
₹1,275
Target Price
₹1,375
Stop Price
₹1,200
Valid Till
Mar 26, 2020 3:20 AM
Margin
₹171,256.25 approx for 500 Qty
Status
Stoploss Hit
Exit Price
₹1,200
Net P&L
-21.9% Loss
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Mar 19 2:46 AM

Update
Stoploss Hit
Exit Price
₹1,200
RJ ROCKET TRADES in APOLLOHOSP
*Big sell apollohospital below 1300 (cash only )*

**What a fall in apollohospital guys 1233 now**
Like
reply
Reply
RJ ROCKET TRADES in APOLLOHOSP
*Big sell apollohospital below 1300 (cash only )*

*Go goa gone guys master stroke 1281 from 1300 enjoy the gain*
*Over and out for the day enjoy your life*
Like
reply
Reply

*Big sell apollohospital below 1300 (cash only )*
Like
reply
Reply

SELL APOLLO HOSPITAL BELOW 1300
Like
reply
Reply (1)
Latest replies
FREE FIRE CALLS @freecalls
Mar 18 5:05 AM

1281.65 LOW💰💰
@newsbot • Reputation: 2,602
Time to revisit midcaps? Citigroup picks top 11 stocks that are worth a look
The valuation discount of midcaps, when compared to largecaps, is close to 10-year high, highlighting the improved risk reward and low expectations.
Moneycontrol
Like
reply
Reply
#ENRICHANSRAJ_PANDEY in APOLLOHOSP
APOLLOHOSP MAR20 FUT
New trade: Buy APOLLOHOSP MAR20 FUT, CMP@1506.6...

APOLLO Hospital stop loss hit 15000 ₹/- loss
Like
reply
Reply
APOLLOHOSP MAR20 1600 CE

Type
Buy
Instrument
APOLLOHOSP MAR20 1600 CE
Entry Price
₹40
Price@Trade
₹35.05
Target Price
₹90
Stop Price
₹17
Valid Till
Mar 26, 2020 3:20 AM
Margin
₹20,000 approx for 500 Qty
Status
Stoploss Hit
Exit Price
₹17
Net P&L
-57.5% Loss
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Mar 16 5:48 AM

Update
Trade Entered
Entry Price
₹40
TrackerBot @trackerbot
Mar 17 8:55 AM

Update
Stoploss Hit
Exit Price
₹17
APOLLOHOSP MAR20 FUT

Type
Buy
Instrument
APOLLOHOSP MAR20 FUT
Entry Price
₹1,505
Price@Trade
₹1,506.65
Target Price
₹1,580
Stop Price
₹1,473
Valid Till
Mar 23, 2020 3:20 AM
Margin
₹145,715.7 approx for 500 Qty
Status
Stoploss Hit
Exit Price
₹1,473
Net P&L
-10.98% Loss
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Mar 16 4:57 AM

Update
Trade Entered
Entry Price
₹1,505
TrackerBot @trackerbot
Mar 16 7:37 AM

Update
Stoploss Hit
Exit Price
₹1,473

APOLLOHOSP - 660742
Performance for the WEEK*
Apollohosp* cmp 1641.20 buy upto 1604.00 stop 1591.00 target 1748.00+
Entry 1620 to 1646.95
*profit ₹ 13475*
Like
reply
Reply
@tradingfab • Reputation: 895

13-03-20 Intraday SELL APOLLOHOSP in cash
only Below @ 1435
Like
reply
Reply (1)
Latest replies
Sameer  @tradingfab
Mar 13 5:52 AM

cancel the order as sell price below @1435 not yet triggered
@stockruns • Reputation: 3,519

APOLLOHOSP - chart - 656435
💰🤑
Like
reply
Reply

APOLLOHOSP - 651368
Due to heavy tanking of markets all trades were not feasable. Posting revised levels for rest of the week*
Apollohosp* cmp 1641.20 buy upto 1604.00 stop 1591.00 target 1748.00+
Like
reply
Reply
@stockruns • Reputation: 3,519
APOLLOHOSP

Type
Sell
Instrument
APOLLOHOSP
Entry Price
₹1,650
Price@Trade
₹1,657
Target Price
₹1,550
Stop Price
₹1,750
Valid Till
Apr 9, 2020 3:20 AM
Margin
₹1,650 approx for 1 Qty
Status
Target Achieved
Exit Price
₹1,550
Net P&L
6.06% Profit
Like
reply
Reply (2)
Latest replies
TrackerBot @trackerbot
Mar 9 3:09 AM

Update
Trade Entered
Entry Price
₹1,650
TrackerBot @trackerbot
Mar 12 2:55 AM

Update
Target Achieved
Exit Price
₹1,550
@stockruns • Reputation: 3,519

APOLLOHOSP - chart - 648148
🤑🤑
Like
reply
Reply

Futures & Options educational trades for the week 9.3.20 to 13.3.20*
(My trade rules apply)
*ALL TRADES SUBJECT TO CORONA PANIC*
#stockmarket
Apollohosp* cmp 1691.20 buy upto 1667.00 stop 1651.00 target 1778.00+
1
reply
Reply
@commodityBiz • Reputation: 15,679

APOLLOHOSP - chart - 647855
👆👆👆👆👆👆👆👆Suggestion :- SELL IF PRICE COMES AGAIN AT 1700 WITH SL OF 1720 FOR TARGET OF 1650
EXPECTATION OF TARGET- 1 DAY
SIGNAL TYPE - STRONG TIME FRAME- 1 HOURS
Like
reply
Reply (1)
Latest replies
Comodity Biz @comodity
Mar 9 4:43 AM

ye commodity biz betichod ka bacha . Isko kuch nhi aata hai . Saala child porn banata hai apni beti ke sath isko jail hona chahie . Ye scam hai isse door raho . iski maa randi hai .
@tanay • Reputation: 20,501
APOLLOHOSP MAR20 FUT

Type
Buy
Instrument
APOLLOHOSP MAR20 FUT
Entry Price
₹1,685
Price@Trade
₹1,689.3
Target Price
₹1,745
Stop Price
₹1,645
Valid Till
Mar 26, 2020 3:20 AM
Status
Expired before entry
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Mar 6 9:11 AM

Update
Expired before entry
Price @ Update
₹1,690
@tanay • Reputation: 20,501
APOLLOHOSP MAR20 FUT

Type
Buy
Instrument
APOLLOHOSP MAR20 FUT
Entry Price
₹1,680
Price@Trade
₹1,689.3
Target Price
₹1,740
Stop Price
₹1,640
Valid Till
Mar 26, 2020 3:20 AM
Status
Expired before entry
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Mar 6 9:11 AM

Update
Expired before entry
Price @ Update
₹1,690

INTRDAY
SELL APOLLO HOSPITAL
BELOW 1720
STOP LOSS 1726
TARGET 1715 1710
Like
reply
Reply

Reversal day for APOLLOHOSP is Mar 6 based on Gann Astro method
Like
reply
Reply
@newsbot • Reputation: 2,602
Phoenix Mills, Apollo Hospitals share price fall, but HSBC sees 7-30% upside
HSBC has maintained buy call on Phoenix Mills and raises target to Rs 1,110 from Rs 1,000 per share.
Moneycontrol
Like
reply
Reply
@tradingfab • Reputation: 895

05-03-20 Intraday BUY APOLLOHOSP in cash
only Above @ 1760
Like
reply
Reply (1)
Latest replies
Sameer  @tradingfab
Mar 5 5:22 AM

cancel the order as buy price above @1760 not yet triggered
@tradingfab • Reputation: 895

05-03-20 Intraday BUY APOLLOHOSP in cash
only Above @ 1769
Like
reply
Reply (1)
Latest replies
Sameer  @tradingfab
Mar 5 3:15 AM

cancel the order as buy price above @1769 not yet triggered
@newsbot • Reputation: 2,602
Market Headstart: Volatility may continue as coronavirus remains a dominant factor
Mounting coronavirus cases, exodus by foreign institutional investors, and RBI playing the waiting game to provide stimulus has prompted investors to exit the market.
Moneycontrol
Like
reply
Reply
@stocktrendr • Reputation: 193

HSBC on Apollo Hospitals: The brokerage maintained a 'buy' call on the stock with the target price at Rs 1,875 per share.
Like
reply
Reply
@newsbot • Reputation: 2,602
Hot Stocks | Why Apollo Hospitals, Alembic Pharma are short-term buys
Nifty on March 4 slid almost 200 points during the day but witnessed a sharp recovery in the second half of the session.
Moneycontrol
Like
reply
Reply
@KetanT • Reputation: -1,335
APOLLOHOSP

Type
Sell
Instrument
APOLLOHOSP
Entry Price
₹1,735
Price@Trade
₹1,742
Target Price
₹1,710
Stop Price
₹1,760
Valid Till
Mar 4, 2020 3:20 AM
Status
Expired before entry
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Mar 4 8:50 AM

Update
Expired before entry
Price @ Update
₹1,754.65
APOLLOHOSP MAR20 1740 PE

Type
Buy
Instrument
APOLLOHOSP MAR20 1740 PE
Entry Price
₹67.35
Price@Trade
₹67.35
Target Price
₹75
Stop Price
₹64
Valid Till
Mar 4, 2020 3:20 AM
Margin
₹33,675 approx for 500 Qty
Status
Stoploss Hit
Exit Price
₹64
Net P&L
-4.97% Loss
Like
reply
Reply (1)
Latest replies
TrackerBot @trackerbot
Mar 4 6:56 AM

Update
Stoploss Hit
Exit Price
₹64
@rajesh-rkU5G57E8 • Reputation: 16
Q. Can we go short now in apollo hospital?
1
reply
Reply (4)
Latest replies
Calls Analyst @callsanalyst
Mar 4 1:02 AM

Tomarrow look you this levels.
👉 Buy at / above: 1753.52   Targets: 1763.12 --- 1773.63 --- 1784.17 --- 1794.74
Stoploss : 1743.06
👉Sell at / below: 1743.06   Targets: 1733.51 --- 1723.11 --- 1712.75 --- 1702.41
Stoploss : 1753.52
Bumblebee OPTION @bumblebee
Mar 5 5:46 AM

Yes can but the stoploss is big now
Calls Analyst @callsanalyst
Mar 5 10:54 AM

Ok make stoploss small you
Calls Analyst @callsanalyst
Mar 5 10:54 AM

From wish you
  • APOLLOHOSP - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization16,985.86
    Enterprise Value19,761.2
    Price to Earnings63.45
    Price to Book Value4.37
    Return on Capital Employed0.09
    Return on Equity0.06
    Face Value5
    Dividend YieldNA
  • APOLLOHOSP Share Price - Technicals

    keyboard_arrow_down
    APOLLOHOSP - 52 Week High₹1,813.55
    APOLLOHOSP - 52 Week Low₹1,047.05
  • APOLLOHOSP - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    10-Dec-19ICICIdirect.comBuy1,800
    26-Jun-19Indiabulls VenturesBuy1,580
    31-May-19ICICIdirect.comBuy1,450
    12-Feb-19EdelweissBuy1,700
    11-Feb-19ICICIdirect.comBuy1,400
    APOLLOHOSP Brokerage Price Target
  • APOLLOHOSP Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Apr 31094.21239.451088.051189.55
    Apr 1113611391080.051088.85
    Mar 3111221155.11047.051139.05
    Mar 30113911671080.151098.25
    Mar 27125912591130.31167
  • APOLLOHOSP Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹1,341.51
    30 Day Moving Average₹1,484.43
    50 Day Moving Average₹1,558.59
    100 Day Moving Average₹1,497.93
    200 Day Moving Average₹1,453.46
  • APOLLOHOSP - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue7,1836,441.770.12
    Operating Profit830774.010.07
    Profit Before Tax330358.92-0.08
    Net Income233285.15-0.18
  • APOLLOHOSP - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds3,8843,6940.05
    Total Liabilities4,5454,688-0.03
    Total Assets8,4288,3820.01
  • APOLLOHOSP - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity539623.51-0.14
    Cash from Investing Activity-378-817.62-0.54
    Cash from Financing Activity-106211.16-1.5
    Net Cash Flow5417.052.17
  • APOLLOHOSP - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.030.04
    Return on Equity0.060.08
    Return on Capital Employed0.090.09
  • APOLLOHOSP - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.56
    3 Year CAGR Growth in Operating Profit0.25
    3 Year CAGR Growth in EBIDTA0.19
    3 Year CAGR Growth in Net Income-0.33
    3 Yr CAGR Growth - Diluted EPS-0.33
  • APOLLOHOSP - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.16
    5 Year CAGR Growth in Operating Profit0.5
    5 Year CAGR Growth in EBIDTA0.43
    5 Year CAGR Growth in Net Income-0.25
    3 Yr CAGR Growth - Diluted EPS-0.25
  • APOLLOHOSP - Recent News

    keyboard_arrow_down
    NewsBot
    Apr 4 1:18 AM
    Lucky 7: HDFC Securities picks fundamentally strong stocks for your portfolio
    Moneycontrol
    NewsBot
    Apr 3 7:23 AM
    Experts name 10 safe bets as valuations seem attractive amid market turmoil
    Moneycontrol
    NewsBot
    Apr 1 7:58 AM
    Coronavirus pandemic: This is how India is trying to overcome ventilator shortage
    Moneycontrol
    NewsBot
    Mar 31 2:33 AM
    Covid-19: Apollo teams up with OYO, Lemon Tree, Ginger Hotels to create 5,000 isolation rooms
    Moneycontrol
    NewsBot
    Mar 27 4:23 AM
    COVID-19 impact | Private hospitals hit hard, steep drop in OPD footfalls
    Moneycontrol
    NewsBot
    Mar 26 1:18 AM
    'Fall in valuation, opportunity for investment but be selective'
    Moneycontrol
    NewsBot
    Mar 25 9:43 AM
    Lockdown, social distancing, visa cancellations to hit hospital earnings
    Moneycontrol
    NewsBot
    Mar 23 7:28 AM
    Kotak upgrades 14 stocks to buy in March after the virus-led correction
    Moneycontrol
    NewsBot
    Mar 16 2:48 AM
    Time to revisit midcaps? Citigroup picks top 11 stocks that are worth a look
    Moneycontrol
    NewsBot
    Mar 5 6:08 AM
    Phoenix Mills, Apollo Hospitals share price fall, but HSBC sees 7-30% upside
    Moneycontrol
  • APOLLOHOSP - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Dr. Reddy's Laboratories Ltd. Sector...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Piramal Enterprises Ltd. Sector: Phar...
    Divi's Laboratories Ltd. Sector: Pha...
    Glenmark Pharmaceuticals Ltd. Sector...
    Strides Pharma Science Ltd. Sector: P...
  • APOLLOHOSP - More Information

    keyboard_arrow_down

    Apollo Hospitals Enterprises Ltd:
    Along with its subsidiaries, Apollo Hospitals Enterprise Limited has been providing healthcare services in India with an international venture. Primary, Secondary, and Tertiary care facilities are comprised of the company. Including cardiac sciences, oncology, critical care, neurosciences, orthopaedics, gastroenterology, and transplants tertiary care hospitals provide care in around 55 specialities. Along with this, the firm is providing different services, including project consultancy, health insurance, education and training program, and research services. Besides that pharmacies, primary care clinics, birthing centres, single-speciality clinics, primary health centres and diagnostic chains, dental clinics, and day-care and home healthcare centres operated by the firm. As of January 2019, the company started running 71 hospitals possessing 10,000 beds; 3,000 pharmacies. The company has 90 primary care and diagnostic clinics and approximately 110 telemedicine centres. Apollo Hospitals Enterprise Limited incepted in 1979 and has it headquarter in Chennai, India.
    Company Information:
    The company, seven years after its inception, added 46 beds in 1985. This group introduced the idea of developing corporate healthcare in India for the first time. Apollo introduced such hospitals which were providing the facility of Magnetic Resonance Imaging (MRI) even in the year of 1989, along with SOMATOMCR which is a Computed Tomography scanner for the entire body; Breast-scanning equipment such as Dideoendoscopy and Mammography were introduced too.
    In August 1991 The Apollo School of Nursing was founded, offering a 3-year diploma programme with an internship in the hospital. The hospital added 16 intensive care beds in 1992, along with developing its equipment in different departments. In 1993, Apollo Cancer Hospital, a premium cancer treatment and research centre, was established with 150-beds in Chennai. Along with that, it introduced the bone marrow transplant facility, developing its cancer project.
    Apollo Hospital Enterprise Limited (AHEL), developed a cancer hospital again in Hyderabad in 1995. In the same year, it was joined in the mission of eradicating Tuberculosis in India under WHO.
    Signing an MOU with Jardine of UK, AHEL adopted the health maintenance organisations (HMO) in 1997, a concept the nation witnessed for the first time. In the next year 1998, an MOU was signed between AHEL and Sri Lankan Government for building a super-speciality hospital in Colombo, which opened the door of AHEL’s international intervention.
    In 2002, the hospital captured the 50.26 % of in the Duncan Gleneagles Hospital against a minimal amount of Rs.3 crore. A tie-up with ICICI Lombard took place in 2003, introducing an accident insurance product. Developing a technology partnership with the Defence Research & Development Organisation (DRDO), AHEL enhanced its strength in 2004.
    Apollo Hospital Delhi was awarded a JCI certificate in 2005 for providing care in a safe environment. In June 2007, AHEL introduced Health City, for the first time in Asia, at Hyderabad with a holistic healthcare delivery facility, with an area of 33 acres mot only for treatment and research but also for hospitality management. In January 2008, an agreement took place between the hospital and the real estate firm Hindustan Construction Co (HCC), for launching a top-class medi-city inside the hill station Lavasa in Maharashtra.
    In June 2012, AHEL declared that International Finance Corporation (IFC) had requested the company for the transformation of the balance loan amount of US$ 7.50 million of Foreign Currency Convertible Bonds (FCCBs) into equity shares. Through making a primary equity infusion of Rs.450 crore, World Bank affiliated International Finance Corporation acquired a 29.03% stake in Apollo Health and Lifestyle Limited (AHLL), a subsidiary of the company, in the year of December 2016.
    Net profit of the company enhanced 28.57% to Rs.76.68 crore in the first quarter of 2019, ending in March against that of the previous quarter ended on March 2018 with Rs.59.64 crore. Similarly, the sales are enhanced by 16.30% to Rs.2167.11 crore in the first quarter of 2019 compared to the sales amount of Rs.1863.42 crore, that the company acquired in the first quarter of 2018.
    How Apollo Hospitals Enterprises Ltd, is categorised as Healthcare Sector, and Hospitals and Medical services Industry :
    Hospital and Medical Services Industry includes companies that are engaged in offering healthcare medical services and also operating standalone pharmacies. They offer services like hospitals, hospital-based pharmacies, consultancy services and projects. Some companies also provide health insurance services, research services and education and training programs.
    Apollo Hospitals Enterprises Ltd is categorized under the Health care sector and Hospitals and Medical services Industry. Healthcare sectors consist of firms involved in the medical space. It is one of the multiple sectors that comprise a range of businesses, including ones that offer medical services directly, or to those that work to develop, create and market medical equipment and medicines. It also includes the other services that provide medical insurance and other related products, and many more.
    The stocks of health care companies mostly have mixed performance. It is due to the inherent challenges to the industry each year, regulatory uncertainties, fiscal policy concerns, and more.
    Apollo Hospitals Enterprises Ltd, Competitors and Sector Peers:
    ADS Diagnostic Ltd. ADSDIA
    ANG Lifesciences India Ltd. ANGLIF
    Artemis Global Life Sciences Ltd. ARTGLO
    Aspira Pathlab & Diagnostics Ltd. ASPPAT
    Aster DM Healthcare Ltd. ASTDMH
    Birla Pacific Medspa Ltd. BIRPAC
    CDR Health Care Ltd. CDRHEA
    Chennai Meenakshi Multispeciality Hospital Ltd. DEVHOS
    Deccan Health Care Ltd. DECHEA
    Dhanvantri Jeevan Rekha Ltd. DHAJEE
    Dolphin Medical Services Ltd. DOLMED
    Dr. Agarwal's Eye Hospital Ltd. DRAGA
    Dr. Lal Pathlabs Ltd. DRLAL
    Dr. Lalchandani Labs Ltd. DRLALL
    Fortis Healthcare Ltd. FORHEA
    Fortis Malar Hospitals Ltd. MALHOS
    Healthcare Global Enterprises Ltd. HEAGLO
    Indo-Global Enterprises Ltd. INDOE
    Indraprastha Medical Corporation Ltd. INDRME
    Kids Medical Systems Ltd. KIDMED
    KMC Speciality Hospitals (India) Ltd. SEAHOS
    Kovai Medical Center and Hospital Ltd. KOVMED
    Looks Health Services Ltd. MONHEA
    Lotus Eye Hospital and Institute Ltd. LOTEYE
    Medinova Diagnostic Services Ltd. MEDDIA
    Metropolis Healthcare Ltd. METHEA
    N G Industries Ltd. NGINDL
    Narayana Hrudayalaya Ltd. NARHRU
    Noida Medicare Centre Ltd. NOIMED
    Regency Hospitals Ltd. REGHOS
    Sakar Healthcare Ltd. SAKHEA
    Scandent Imaging Ltd. PHACOM
    Secunderabad Healthcare Ltd. SECHEA
    Shalby Ltd. SHALLT
    Soni Medicare Ltd. SONMED
    STG Lifecare Ltd. STGTEC
    Tejnaksh Healthcare Ltd. TEJHEA
    Thyrocare Technologies Ltd. THYTEC
    Vimta Labs Ltd. VIMLAB
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.